Pricing Log in Create free account

Celcuity, Inc. (CELC) vs Viridian Therapeutics, Inc. (VRDN)

Celcuity, Inc. and Viridian Therapeutics, Inc. are both Biotechnology companies. Celcuity, Inc. and Viridian Therapeutics, Inc. are of similar size ($3.2B and $3.1B). Celcuity, Inc. has the higher net margin (0.00% vs −1,724.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Celcuity, Inc. leads on 8 and Viridian Therapeutics, Inc. on 4.

Valuation

Metric CELC VRDN Biotechnology median
P/E n/m n/m 10.26
P/S n/m 117.81 9.18
P/B n/m 5.49 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 91.03 8.98
Earnings yield (6.66%) (11.73%) (34.89%)
Free cash flow yield (5.43%) (11.08%) (24.52%)

Profitability

Metric CELC VRDN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (1,781.38%) 0.00%
Net margin 0.00% (1,724.06%) 0.00%
Free cash flow margin 0.00% (1,305.42%) 0.00%
Return on equity (1,433.70%) 0.00% (50.12%)
Return on assets (44.77%) (56.49%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CELC VRDN Biotechnology median
Revenue growth (TTM) — (62.83%) 6.26%
EPS growth (last fiscal year) (33.92%) (8.14%) 29.88%
Revenue growth, 5-year CAGR — 132.18% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELC VRDN Biotechnology median
Debt to equity (58.93) 0.00 0.00
Current ratio 8.93 14.46 4.89
Net debt to EBITDA 0.71 2.23 1.01

Dividend

Metric CELC VRDN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CELC VRDN Biotechnology median
Market cap 3.13b 3.23b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack